• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于胶质瘤靶向治疗的姜黄素纳米囊泡的研发与评估

Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy.

作者信息

Qian Hao, Lv Jiaqi, Hu Xiuping

机构信息

Department of Pharmacy, The Affiliated Chuzhou Hospital of Anhui Medical University, 369th Zhuwengxi Road, Nanqiao District, Chuzhou, 239000, China.

Tianjin University of Science and Technology, 1038th Dagu Nan Road, Hexi District, Tianjin, China.

出版信息

Sci Rep. 2025 Mar 27;15(1):10520. doi: 10.1038/s41598-025-95348-5.

DOI:10.1038/s41598-025-95348-5
PMID:40140588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11947147/
Abstract

Glioma remains a significant global health challenge, and is characterized by a persistently high mortality rate. Chemotherapy is a common treatment for glioma, but many anticancer drugs exhibit poor permeability across the blood-brain barrier (BBB) and fail to reach tumor tissues adequately, while also exerting toxic effects on normal cells. To address these issues, this study investigated the use of niosomes (Nio), which are biocompatible, biodegradable, and non-immunogenic, to encapsulate curcumin (Cur) and enhance its delivery to glioma tissues. Niosomes were prepared using the non-ionic surfactant sorbitan monostearate (Span 60) and cholesterol as carrier materials, and subsequently modified with transferrin (TF) to facilitate receptor-mediated transport across the BBB. The resulting TF-modified curcumin niosomes (TF-Cur-Nio) demonstrated enhanced targeting of brain tumors, improved anti-glioma efficacy, and favorable in vivo safety. These findings suggest that the TF-Cur-Nio delivery system has significant potential for advancing glioma treatment by overcoming the limitations of conventional chemotherapy and improving drug delivery to the brain.

摘要

胶质瘤仍然是一项重大的全球健康挑战,其特点是死亡率持续居高不下。化疗是治疗胶质瘤的常用方法,但许多抗癌药物在血脑屏障(BBB)中的渗透性较差,无法充分到达肿瘤组织,同时还会对正常细胞产生毒性作用。为了解决这些问题,本研究调查了使用具有生物相容性、可生物降解且无免疫原性的脂质体(Nio)来包裹姜黄素(Cur)并增强其向胶质瘤组织的递送。使用非离子表面活性剂单硬脂酸山梨醇酯(Span 60)和胆固醇作为载体材料制备脂质体,随后用转铁蛋白(TF)进行修饰,以促进通过血脑屏障的受体介导转运。所得的转铁蛋白修饰的姜黄素脂质体(TF-Cur-Nio)表现出对脑肿瘤的靶向性增强、抗胶质瘤疗效提高以及良好的体内安全性。这些发现表明,TF-Cur-Nio递送系统通过克服传统化疗的局限性并改善药物向脑部的递送,在推进胶质瘤治疗方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/e565e5176c2e/41598_2025_95348_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/771a053d65e2/41598_2025_95348_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/c47e04853cd3/41598_2025_95348_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/cb717887b91b/41598_2025_95348_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/e565e5176c2e/41598_2025_95348_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/771a053d65e2/41598_2025_95348_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/c47e04853cd3/41598_2025_95348_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/cb717887b91b/41598_2025_95348_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db4/11947147/e565e5176c2e/41598_2025_95348_Fig4_HTML.jpg

相似文献

1
Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy.用于胶质瘤靶向治疗的姜黄素纳米囊泡的研发与评估
Sci Rep. 2025 Mar 27;15(1):10520. doi: 10.1038/s41598-025-95348-5.
2
Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.环六肽偶联纳米颗粒增强姜黄素向胶质瘤肿瘤细胞和组织的递送。
Int J Nanomedicine. 2017 Aug 8;12:5717-5732. doi: 10.2147/IJN.S138501. eCollection 2017.
3
A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.一种靶向脑部的双介导脂质体药物递送系统:合理构建、血脑屏障完整性评估及向胶质瘤细胞的转运机制
Int J Nanomedicine. 2017 Mar 28;12:2407-2425. doi: 10.2147/IJN.S131367. eCollection 2017.
4
Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats.转铁蛋白修饰的多柔比星载生物可降解纳米粒在治疗脑胶质瘤荷瘤大鼠中显示出更好的疗效。
Cancer Biother Radiopharm. 2013 Nov;28(9):691-6. doi: 10.1089/cbr.2013.1480. Epub 2013 Jun 20.
5
Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.细胞穿透肽和转铁蛋白共修饰脂质体用于脑胶质瘤的靶向治疗。
Molecules. 2019 Sep 30;24(19):3540. doi: 10.3390/molecules24193540.
6
A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy.一种用于协同性胶质瘤化疗的靶向响应纳米前药递送系统。
Small. 2024 Jul;20(30):e2400630. doi: 10.1002/smll.202400630. Epub 2024 Mar 3.
7
Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes.姜黄素纳米脂质体对颅内神经胶质瘤模型小鼠的靶向治疗。
Int J Nanomedicine. 2018 Mar 15;13:1601-1610. doi: 10.2147/IJN.S157019. eCollection 2018.
8
Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.双靶向阿霉素脂质体对神经胶质瘤的靶向作用及血脑屏障穿透性。
Biomaterials. 2013 Jul;34(22):5628-39. doi: 10.1016/j.biomaterials.2013.03.097. Epub 2013 Apr 26.
9
Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.转铁蛋白靶向纳米颗粒共递送阿霉素和pH敏感姜黄素前药用于乳腺癌治疗
Oncol Rep. 2017 Feb;37(2):1253-1260. doi: 10.3892/or.2017.5345. Epub 2017 Jan 2.
10
Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.转铁蛋白修饰的聚乳酸-共-羟基乙酸纳米粒的制备及其在神经胶质瘤治疗中的应用。
Anticancer Drugs. 2019 Jul;30(6):604-610. doi: 10.1097/CAD.0000000000000754.

本文引用的文献

1
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.脑靶向药物递送 - 通过脑靶向配体将纳米囊泡递送到特定的脑细胞。
J Nanobiotechnology. 2024 May 17;22(1):260. doi: 10.1186/s12951-024-02511-7.
2
Current advances in niosomes applications for drug delivery and cancer treatment.非离子表面活性剂囊泡在药物递送和癌症治疗中的应用现状进展
Mater Today Bio. 2023 Oct 21;23:100837. doi: 10.1016/j.mtbio.2023.100837. eCollection 2023 Dec.
3
Liposomes: structure, composition, types, and clinical applications.
脂质体:结构、组成、类型及临床应用。
Heliyon. 2022 May 13;8(5):e09394. doi: 10.1016/j.heliyon.2022.e09394. eCollection 2022 May.
4
Engineering the Architecture of Elastin-Like Polypeptides: From Unimers to Hierarchical Self-Assembly.工程化弹性蛋白样多肽的结构:从单体到分级自组装
Adv Ther (Weinh). 2020 Mar;3(3). doi: 10.1002/adtp.201900164. Epub 2020 Feb 3.
5
Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses.用于生物医学用途的聚合物纳米颗粒稳定化的非离子表面活性剂。
Materials (Basel). 2021 Jun 10;14(12):3197. doi: 10.3390/ma14123197.
6
Self-assembly of surfactants: An overview on general aspects of amphiphiles.表面活性剂的自组装:两亲分子的一般方面概述。
Biophys Chem. 2020 Oct;265:106429. doi: 10.1016/j.bpc.2020.106429. Epub 2020 Jul 8.
7
Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.近年来非离子表面活性剂囊泡(niosomes)的研究进展:制备、表征、药物和化妆品应用。
Eur J Pharm Biopharm. 2019 Nov;144:18-39. doi: 10.1016/j.ejpb.2019.08.015. Epub 2019 Aug 22.
8
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.纳米载体的进步使药物能够穿透血脑屏障靶向递送到大脑。
Int J Pharm. 2019 Mar 25;559:360-372. doi: 10.1016/j.ijpharm.2019.01.056. Epub 2019 Feb 2.
9
Suggested Procedures for the Reproducible Synthesis of Poly(d,l-lactide-co-glycolide) Nanoparticles Using the Emulsification Solvent Diffusion Platform.使用乳化溶剂扩散平台可重复合成聚(d,l-丙交酯-共-乙交酯)纳米颗粒的建议程序。
Curr Nanosci. 2018 Oct;14(5):448-453. doi: 10.2174/1573413714666180313130235.
10
Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation.聚合物纳米粒用于抗癌药物的静脉递药:从合成到临床转化道路上的关键点。
Nanoscale. 2018 Dec 13;10(48):22701-22719. doi: 10.1039/c8nr05933k.